Proton Pump Inhibitors - CME Conferences

6 th Annual Primary Care Spring Conference Thursday, April 12, 2012
April 20, 2011 —A report from the IMS Institute
for Healthcare Informatics
• For Americans covered by insurance,
Medicare, or Medicaid, the average copayment
for a prescription was $10.73 -- down
a bit from 2009 due to increased use of generic
drugs.
• The average co-payment for branded drugs for
which generic alternatives were available
jumped 6% to $22.73.
In 2010 the 10 drugs on which we
spent the most were:
1. Lipitor (atorvastatin)-- $7.2 billion (11-2011)
2. Nexium (esomeprazole)-- $6.3 billion
3. Plavix (clopidogrel) -- $6.1 billion (5-2012)
4. Advair Diskus (salmeterol/fluticazone)-- $4.7 billion
5. Abilify (aripiprazole)-- $4.6 billion
6. Seroquel (quetiapine)-- $4.4 billion (3-2012)
7. Singulair (montelukast)-- $4.1 billion (8-2012)
8. Crestor (rosuvastatin)-- $3.8 billion
9. Actos (pioglitazone)-- $3.5 billion (8-2012)
10. Epogen (epoetin alfa)-- $3.3 billion
2010 IMS report:
Wayne Weart, Pharm D
Cost Effective Rx